Improving Nutrition and Activity Behaviors Using Digital Technology and Tailored Feedback: Protocol for the Tailored Diet and Activity (ToDAy) Randomized Controlled Trial
Overview
Authors
Affiliations
Background: Excess weight is a major risk factor for chronic diseases. In Australia, over 60% of adults are overweight or obese. The overconsumption of energy-dense nutrient-poor (EDNP) foods and low physical activity (PA) levels are key factors contributing to population obesity. New cost-effective approaches to improve population diet and PA behaviors are needed.
Objective: This 1-year randomized controlled trial (6-month intervention and 6-month follow-up) aims to investigate whether a tailored intervention using mobile technology can improve diet and PA behaviors leading to weight loss in adults (aged 18-65 years) who are overweight or obese and recruited through a social marketing campaign (LiveLighter).
Methods: All eligible participants will provide data on demographics and lifestyle behaviors online at baseline, 6 months, and 12 months. Using two-stage randomization, participants will be allocated into one of three conditions (n=200 per group): tailored feedback delivered via email at seven time points, informed by objective dietary (mobile food record app) and activity (wearable activity monitor) assessment; active control receiving no tailored feedback, but undergoing the same objective assessments as tailored feedback; and online control receiving no tailored feedback or objective assessments. Primary outcome measures at 6 and 12 months are changes in body mass, EDNP food and beverage consumption, and daily moderate-to-vigorous PA (measured via accelerometry). Secondary outcomes include change in fruit and vegetable consumption, daily sedentary behaviors, and cost effectiveness.
Results: Enrolment commenced in August 2017. Primary outcomes at 12 months will be available for analysis from September 2019.
Conclusions: Tailored email feedback provided to individuals may deliver a cost-effective strategy to overcome existing barriers to improving diet and PA. If found to be successful and cost effective, upscaling this intervention for inclusion in larger-scale interventions is highly feasible.
Trial Registration: Australian New Zealand Clinical Trials Registry ACTRN12617000554369; https://www.anzctr.org.au /Trial/Registration/TrialReview.aspx?id=371325&isReview=true.
International Registered Report Identifier (irrid): DERR1-10.2196/12782.
Metzendorf M, Wieland L, Richter B Cochrane Database Syst Rev. 2024; 2:CD013591.
PMID: 38375882 PMC: 10877670. DOI: 10.1002/14651858.CD013591.pub2.
Barrett B Prev Med Rep. 2022; 28:101878.
PMID: 35832638 PMC: 9272027. DOI: 10.1016/j.pmedr.2022.101878.
Whitton C, Healy J, Dhaliwal S, Shoneye C, Harray A, Mullan B Br J Nutr. 2022; :1-39.
PMID: 35587722 PMC: 9899562. DOI: 10.1017/S0007114522001532.
Johansson J, Lam N, Ozer S, Hall J, Morton S, English C BMJ Open. 2022; 12(1):e053945.
PMID: 35105631 PMC: 8804646. DOI: 10.1136/bmjopen-2021-053945.
Braakhuis A, Gillies N, Worthington A, Knowles S, Conner T, Roy R JMIR Res Protoc. 2021; 10(12):e30909.
PMID: 34931994 PMC: 8734916. DOI: 10.2196/30909.